These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16411303)

  • 1. Medicare and cost-effectiveness analysis.
    Smolkin MT
    N Engl J Med; 2006 Jan; 354(2):207-9; author reply 207-9. PubMed ID: 16411303
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness in a flat world--can ICDs help the United States get rhythm?
    Goldman L
    N Engl J Med; 2005 Oct; 353(14):1513-5. PubMed ID: 16207856
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
    J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillators.
    Mack MJ
    N Engl J Med; 2005 May; 352(19):2022-5; author reply 2022-5. PubMed ID: 15888706
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of ICDs.
    Fauchier L; Babuty D
    N Engl J Med; 2006 Jan; 354(2):205-7; author reply 205-7. PubMed ID: 16411302
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of ICDs.
    Stevenson LW; Stevenson WG
    N Engl J Med; 2006 Jan; 354(2):205-7; author reply 205-7. PubMed ID: 16411295
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of ICDs.
    Anderson KP
    N Engl J Med; 2006 Jan; 354(2):205-7; author reply 205-7. PubMed ID: 16407520
    [No Abstract]   [Full Text] [Related]  

  • 8. Defibrillators in heart failure and quality of life.
    Matlock DD
    N Engl J Med; 2009 Jan; 360(2):187-8; author reply 189. PubMed ID: 19129534
    [No Abstract]   [Full Text] [Related]  

  • 9. How should we cost ICD therapy?
    Fox DJ; Davidson NC; Fitzpatrick AP
    Int J Cardiol; 2007 May; 118(1):1-3. PubMed ID: 17258335
    [No Abstract]   [Full Text] [Related]  

  • 10. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Mark DB; Nelson CL; Anstrom KJ; Al-Khatib SM; Tsiatis AA; Cowper PA; Clapp-Channing NE; Davidson-Ray L; Poole JE; Johnson G; Anderson J; Lee KL; Bardy GH;
    Circulation; 2006 Jul; 114(2):135-42. PubMed ID: 16818817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression methods for cost-effectiveness analysis with censored data.
    Willan AR; Lin DY; Manca A
    Stat Med; 2005 Jan; 24(1):131-45. PubMed ID: 15515137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shock treatment. Medicare's coverage of implantable defibrillators adds jolt to electrophysiology specialty, device sales.
    Becker C
    Mod Healthc; 2005 May; 35(19):34, 36. PubMed ID: 15929257
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfer regulations and cost-effectiveness analysis.
    Posner EA
    Duke Law J; 2003 Dec; 53(3):1067-110. PubMed ID: 15260020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grasping the role of technology: a conversation with Ron Dollens. Interview by John K. Iglehart.
    Dollens R
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-296-W5-313. PubMed ID: 15975988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
    Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
    Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of the implantable cardioverter defibrillator.
    Roberts PR; Betts TR; Morgan JM
    Eur Heart J; 2000 May; 21(9):712-9. PubMed ID: 10739726
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare coverage for technological innovations--time for new criteria?
    Gillick MR
    N Engl J Med; 2004 May; 350(21):2199-203. PubMed ID: 15152067
    [No Abstract]   [Full Text] [Related]  

  • 19. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ; Woo A; Ko DT; Cameron DA; Mihailovic A; Krahn M
    Am Heart J; 2007 Nov; 154(5):899-907. PubMed ID: 17967596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of implantable defibrillators: perceptions and reality.
    Camm J; Klein H; Nisam S
    Eur Heart J; 2007 Feb; 28(4):392-7. PubMed ID: 16887857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.